Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17606130.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacillus Calmette-Guérin (BCG) is a live attenuated strain of Mycobacterium bovis that has proven effective in the treatment of early-stage bladder cancer. Although intravesical therapy with BCG is generally considered safe, serious complications including hematuria, granulomatous pneumonitis, hepatitis, and life-threatening BCG sepsis are well known. BCG-related vascular infections are rarely reported. We present a case of a ruptured abdominal aortic aneurysm secondary to M bovis infection 2 years after intravesical instillation of BCG and review the related literature.
Medical subject headings
- Aneurysm, Infected
- Antineoplastic Agents
- Aortic Aneurysm, Abdominal
- Aortic Rupture
- BCG Vaccine
- Carcinoma, Transitional Cell
- Mycobacterium bovis
- Tuberculosis, Cardiovascular
- Urinary Bladder Neoplasms